Overall our findings suggest that five genes CXCL3, MET, IL1B, IL1A and TNS1 that were screened through the integrated bioinformatics approach have the potential to serve as biomarkers in early age CRC patients. This evidence concerns the gene MET and colorectal carcinoma.